Poly (ADP-Ribose) polymerase inhibitors (PARPI): Associated thrombosis in patients with ovarian cancer

被引：0

作者：

Sanchez Canovas, M. ^{[1
]}

Lopez Robles, J. ^{[1
]}

Garcia Verdejo, F. J. ^{[2
]}

Cacho Lavin, D. ^{[3
]}

Guirao, S. ^{[4
]}

Garrido Fernandez, A. ^{[5
]}

Coma Salvans, E. ^{[6
]}

Quintanar Verduguez, T. ^{[7
]}

Salvador Coloma, C. ^{[8
]}

Fernandez Garay, D. ^{[9
]}

Cumplido, J. D. ^{[10
]}

Ferrer Perez, A. I. ^{[11
]}

Carbo Bague, A. ^{[12
]}

Teigell Munoz, F. J. ^{[13
]}

Munoz Martin, A. J. ^{[14
]}

机构：

[1] Hosp Gen Univ Morales Meseguer, Med Oncol Dept, Murcia, Spain

[2] Hosp Univ Jaen, Med Oncol Dept, Jaen, Spain

[3] HUMV Hosp Univ Marques de Valdecilla, Med Oncol, Santander, Spain

[4] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain

[5] Hosp Univ Alvaro Cunqueiro, Med Oncol Dept, Pontevedra, Spain

[6] Hosp Duran & Reynals, ICO Inst Catala Oncol lHospitalet, Med Oncol Dept, Lhospitalet De Llobregat, Spain

[7] Hosp Gen Univ Elche, Med Oncol Dept, Alicante, Spain

[8] Hosp Lluis Alcanyis Xativa, Med Oncol Dept, Valencia, Spain

[9] Hosp Costa del Sol, Agencia Sanitaria Costa del Sol, Med Oncol Dept, Marbella, Spain

[10] Hosp Univ Torrevieja, Med Oncol Dept, Torrevieja, Spain

[11] Obispo Polanco Hosp, Med Oncol Dept, Teruel, Spain

[12] ICO Girona Inst Catala Oncol Girona, Med Oncol Dept, Girona, Spain

[13] Hosp Univ Infanta Cristina, Internal Med Dept, Parla, Spain

[14] Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Madrid, Spain

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.08.1955

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1861P

引用

页码：S1095 / S1095

页数：1

共 50 条

[41] Poly(ADP-ribose) polymerase inhibitors: toxicity and costs
Reactions Weekly, 2020, 1819 (1) : 9 - 9
[42] Comparative Analyses of Poly(ADP-Ribose) Polymerase Inhibitors
Guha, Mausumee
Sobol, Zhanna
Martin, Mathew
Hemkens, Michelle
Sung, Tae
Rubitski, Elizabeth
Spellman, Richard
Finkelstein, Martin
Khan, Nasir
Hu, Wenyue
INTERNATIONAL JOURNAL OF TOXICOLOGY, 2022, 41 (06) : 442 - 454
[43] The clinical development of inhibitors of poly(ADP-ribose) polymerase
Calvert, H.
Azzariti, A.
ANNALS OF ONCOLOGY, 2011, 22 : i53 - i59
[44] Poly(ADP-Ribose) Polymerase Inhibitors (PARPi) for patients (pts) with locally advanced or metastatic breast cancer (BC): A meta-analysis.
Tio, Martin
Patil, Sujata
Traina, Tiffany A.
Robson, Mark E.
Khasraw, Mustafa
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[45] New inhibitors of poly(ADP-ribose) polymerase (PARP)
Peukert, S
Schwahn, U
EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (11) : 1531 - 1551
[46] Nanoparticle Formulations of Poly (ADP-ribose) Polymerase Inhibitors for Cancer Therapy
Singh, Bijay
Yang, Shicheng
Krishna, Apurva
Sridhar, Srinivas
FRONTIERS IN CHEMISTRY, 2020, 8
[47] The Emerging Role of Poly(ADP-Ribose) Polymerase Inhibitors in Cancer Treatment
Sandhu, Shahneen K.
Yap, Timothy A.
de Bono, Johann S.
CURRENT DRUG TARGETS, 2011, 12 (14) : 2034 - 2044
[48] The therapeutic potential of poly(ADP-ribose) polymerase inhibitors
Virág, L
Szabó, C
PHARMACOLOGICAL REVIEWS, 2002, 54 (03) : 375 - 429
[49] Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase
Menear, Keith A.
Adcock, Claire
Alonso, Francisco Cuenca
Blackburn, Kristel
Copsey, Louise
Drzewiecki, Jan
Fundo, Alexandra
Le Gall, Armelle
Gomez, Sylvie
Javaid, Hashim
Lence, Carlos Fenandez
Martin, Niall M. B.
Mydlowski, Chris
Smith, Graeme C. M.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 3942 - 3945
[50] Poly(ADP-ribose) polymerase inhibitors in Ewing sarcoma
Vormoor, Britta
Curtin, Nicola J.
CURRENT OPINION IN ONCOLOGY, 2014, 26 (04) : 428 - 433

← 1 2 3 4 5 →